Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 1/7/2020
SIETES contiene 93059 citas

<< anterior 41 a 60 de 148 siguiente >>
Presentar resultados
Seleccionar todas
42. Cita con resumen
Anónimo. FDA requires lower dosing of zolpidem. Med Lett Drugs Ther 2013;55:5. [Ref.ID 94800]
43.Tiene citas relacionadas Cita con resumen
Widera E. What's to blame for falls and fractures? Poor sleep or the sleeping medication?. JAMA Intern Med 2013;173:761-2. [Ref.ID 94772]
44.Tiene citas relacionadas Cita con resumen
Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 2013;173:754-61. [Ref.ID 94771]
45. Cita con resumen
Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Sirwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ 2013;346:10. [Ref.ID 94724]
46. Cita con resumen
Cunnington D. Non-benzodiazepine hypnotics: do they work for insomnia?. BMJ 2013;346:8. [Ref.ID 94723]
47. Cita con resumen
Kolla BP, Lovely JK, Mansukhani MP, Morgenthaler TI. Zolpidem is independently associated with increased risk of inpatient falls. J Hosp Med 2013;8:1-6. [Ref.ID 94695]
49.Tiene citas relacionadas Cita con resumen
Billioti de Gage SB, Bégaud B, Bazin F, Verdoux H, Dartigues J-F, Pérès K, Kurth T, Pariente A. Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012;345:14. [Ref.ID 93062]
Leschziner G, Gringras P. Restless legs syndrome. BMJ 2012;344:38-41. [Ref.ID 93007]
51. Cita con resumen
Anónimo. Low-dose sublingual zolpidem (Intermezzo) for insomnia due to middle-of-the-night awakening. Med Lett Drugs Ther 2012;54:25-6. [Ref.ID 92665]
52. Cita con resumen
Anónimo. Zolpidem: continued reporting of abnormal sleep-related events and amnesia. Australian Prescriber 2012;35:99. [Ref.ID 92636]
53. Cita con resumen
Morin CM, Benca R. Chronic insomnia. Lancet 2012;379:1129-41. [Ref.ID 92548]
54. Cita con resumen
Anónimo. Zolpidem oral spray (Zolpimist) for insomnia. Med Lett Drugs Ther 2012;54:14-5. [Ref.ID 92428]
55. Cita con resumen
Anónimo. Zolpidem tartrate - Association with complex sleep behaviours. Canada. WHO Pharmaceuticals Newsletter 2012;1:14. [Ref.ID 92206]
56. Cita con resumen
Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2012:28 de febrero. [Ref.ID 92169]
57. Cita con resumen
Anónimo. Hypnotics. MeReC Bulletin 2012;22:8-10. [Ref.ID 92154]
58. Cita con resumen
Finkle WD, Der JS, Greenland S, Adams JL, RidgewayG, Blaschke T, Wang Z, Dell RM, VanRiper KB. Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011;59:1883-90. [Ref.ID 91890]
59.Tiene citas relacionadas Cita con resumen
de Boer A. When to publish measures of disproportionality derived from spontaneous reporting databases?. Br J Clin Pharmacol 2011;72:909-11. [Ref.ID 91874]
60.Tiene citas relacionadas Cita con resumen
Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strenghts of the disproportionality analysis of identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol 2011;72:905-8. [Ref.ID 91873]
Seleccionar todas
<< anterior 41 a 60 de 148 siguiente >>